• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Planning and priority setting for vaccine development and immunization.疫苗研发与免疫接种的规划及优先事项设定。
Vaccine. 2017 Jan 20;35 Suppl 1:A50-A56. doi: 10.1016/j.vaccine.2016.09.072. Epub 2016 Dec 22.
2
Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher Education.人口健康与公共卫生实践中的战略规划:对高等教育的行动呼吁。
Milbank Q. 2016 Mar;94(1):109-25. doi: 10.1111/1468-0009.12182.
3
Bridging the gap: need for a data repository to support vaccine prioritization efforts.缩小差距:需要一个数据存储库来支持疫苗优先排序工作。
Vaccine. 2015 Jun 8;33 Suppl 2(0 2):B34-9. doi: 10.1016/j.vaccine.2015.02.032.
4
Multi-criteria decision analysis to prioritize the introduction of new vaccines in Indonesia by using the framework of the strategic multi-attribute ranking tool for vaccines (SMART vaccines).多准则决策分析在印度尼西亚采用疫苗战略多属性排名工具(SMART 疫苗)框架优先引入新疫苗。
Expert Rev Vaccines. 2021 Jan;20(1):83-91. doi: 10.1080/14760584.2021.1874926. Epub 2021 Jan 21.
5
Informing vaccine decision-making: A strategic multi-attribute ranking tool for vaccines-SMART Vaccines 2.0.为疫苗决策提供信息:一种用于疫苗的战略性多属性排序工具——智能疫苗2.0
Vaccine. 2017 Jan 20;35 Suppl 1:A43-A45. doi: 10.1016/j.vaccine.2016.10.086. Epub 2016 Dec 22.
6
Calling the shots: immunization finance policies and practices. Executive summary of the report of the Institute of Medicine.掌控局面:免疫接种筹资政策与实践。医学研究所报告执行摘要
Am J Prev Med. 2000 Oct;19(3 Suppl):4-12. doi: 10.1016/s0749-3797(00)00212-9.
7
Developments in immunization planning in Cambodia--rethinking the culture and organization of national program planning.柬埔寨免疫规划的发展——对国家规划的文化与组织进行反思
Rural Remote Health. 2007 Apr-Jun;7(2):630. Epub 2007 May 18.
8
Helicobacter pylori vaccine development and use: a cost-effectiveness analysis using the Institute of Medicine Methodology.幽门螺杆菌疫苗的研发与应用:采用医学研究所方法进行的成本效益分析
Helicobacter. 1999 Dec;4(4):272-80. doi: 10.1046/j.1523-5378.1999.99311.x.
9
TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.TRIVAC 决策支持模型评估 b 型流感嗜血杆菌、肺炎球菌和轮状病毒疫苗接种的成本效益。
Vaccine. 2013 Jul 2;31 Suppl 3:C19-29. doi: 10.1016/j.vaccine.2013.05.045.
10
What criteria do decision makers in Thailand use to set priorities for vaccine introduction?泰国的决策者依据哪些标准来确定疫苗引入的优先顺序?
BMC Public Health. 2016 Aug 2;16:684. doi: 10.1186/s12889-016-3382-5.

引用本文的文献

1
Pathway towards an ideal and sustainable framework agreement for the public procurement of vaccines in Spain: a multi-criteria decision analysis.西班牙疫苗公共采购理想且可持续框架协议的达成路径:多标准决策分析
Hum Vaccin Immunother. 2020 Nov 1;16(11):2873-2884. doi: 10.1080/21645515.2020.1732164. Epub 2020 Apr 3.

本文引用的文献

1
Beyond cost-effectiveness: Using systems analysis for infectious disease preparedness.超越成本效益:运用系统分析进行传染病防范。
Vaccine. 2017 Jan 20;35 Suppl 1:A46-A49. doi: 10.1016/j.vaccine.2016.08.090. Epub 2016 Dec 22.
2
Multicriteria decision analysis and core values for enhancing vaccine-related decision-making.多准则决策分析及其核心价值观在增强疫苗相关决策中的应用。
Sci Transl Med. 2016 Jun 29;8(345):345ps14. doi: 10.1126/scitranslmed.aaf0756.
3
Strategic Planning in Population Health and Public Health Practice: A Call to Action for Higher Education.人口健康与公共卫生实践中的战略规划:对高等教育的行动呼吁。
Milbank Q. 2016 Mar;94(1):109-25. doi: 10.1111/1468-0009.12182.
4
Bridging the gap: need for a data repository to support vaccine prioritization efforts.缩小差距:需要一个数据存储库来支持疫苗优先排序工作。
Vaccine. 2015 Jun 8;33 Suppl 2(0 2):B34-9. doi: 10.1016/j.vaccine.2015.02.032.
5
A priority-setting aid for new vaccine candidates.新型候选疫苗的优先排序辅助工具。
Proc Natl Acad Sci U S A. 2014 Mar 4;111(9):3199-200. doi: 10.1073/pnas.1400945111.
6
The structure, role, and procedures of the U.S. Advisory Committee on Immunization Practices (ACIP).美国免疫实践咨询委员会(ACIP)的结构、作用和程序。
Vaccine. 2010 Apr 19;28 Suppl 1:A68-75. doi: 10.1016/j.vaccine.2010.02.037.

疫苗研发与免疫接种的规划及优先事项设定。

Planning and priority setting for vaccine development and immunization.

作者信息

Phelps Charles E, Madhavan Guruprasad, Gellin Bruce

机构信息

University of Rochester, Rochester, NY, United States.

The National Academies of Sciences, Engineering, and Medicine, Washington, DC, United States.

出版信息

Vaccine. 2017 Jan 20;35 Suppl 1:A50-A56. doi: 10.1016/j.vaccine.2016.09.072. Epub 2016 Dec 22.

DOI:10.1016/j.vaccine.2016.09.072
PMID:28017444
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7131338/
Abstract

We review a sequence of strategic planning efforts over time in the United States, all involving processes to prioritize new vaccine candidates. The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine has been involved in three priority setting processes, each using different metrics and methodologies: infant mortality equivalents (1985-1986), cost-effectiveness (2000), and more recently, the implementation of a software system based on a broader multi-criteria systems approach that can include either of the earlier metrics among other various considerations (2015). The systems approach offers users the flexibility to select, combine, rank, weigh and evaluate different attributes representing their perspectives, assumptions, and particular needs. This approach also overcomes concerns relating to the previous single-metric ranking approaches that yielded lists that, once published, were static, and could not readily accommodate new information about emerging pathogens, new scientific advances, or changes in the costs and performance features of interventions. We discuss the rationale and reasoning behind the design of this multi-criteria decision support approach, stakeholder feedback about the tool, and highlight the potential advantages from using this expanded approach to better inform and support vaccine policies.

摘要

我们回顾了美国一段时间内一系列战略规划工作,所有这些工作都涉及对新疫苗候选品种进行优先排序的过程。美国国家科学院、工程院和医学院的医学研究所参与了三个优先排序过程,每个过程使用不同的指标和方法:婴儿死亡率当量(1985 - 1986年)、成本效益(2000年),以及最近基于更广泛的多标准系统方法实施的一个软件系统,该方法在其他各种考虑因素中可以纳入早期的任何一个指标(2015年)。该系统方法为用户提供了灵活性,使其能够选择、组合、排序、权衡和评估代表其观点、假设和特定需求的不同属性。这种方法还克服了与以前单一指标排名方法相关的问题,以前的方法产生的列表一旦公布就是固定的,无法轻易纳入有关新出现病原体的新信息、新的科学进展,或干预措施成本及性能特征的变化。我们讨论了这种多标准决策支持方法设计背后的基本原理和推理、利益相关者对该工具的反馈,并强调了使用这种扩展方法为疫苗政策提供更好信息和支持的潜在优势。